Medistim ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	699.77	556.16	521.11	486.26	417.82
Revenue Growth (YoY)	25.82%	6.73%	7.17%	16.38%	17.30%
Cost of Revenue	128.17	113.68	112.28	106.49	97.11
Gross Profit	571.59	442.48	408.83	379.78	320.7
Selling, General & Admin	230.34	174.35	150.2	136.51	124.02
Other Operating Expenses	120.23	112.55	103.53	78.73	62.27
Operating Expenses	375.4	311.41	277.39	238.53	209.72
Operating Income	196.2	131.08	131.44	141.25	110.99
Interest Expense	-16.85	-	-	-0.12	-0.18
Interest & Investment Income	-	4.57	3.28	0.92	0.02
Currency Exchange Gain (Loss)	-	-1.63	0.93	3.06	-1.81
Other Non Operating Income (Expenses)	27.5	0.23	-0.44	0.94	-0.24
EBT Excluding Unusual Items	206.85	134.25	135.21	146.05	108.78
Other Unusual Items	-	-	-	-	5.29
Pretax Income	206.85	134.25	135.21	146.05	114.07
Income Tax Expense	47.64	30.41	31.39	32.08	23.17
Net Income	159.21	103.83	103.82	113.97	90.9
Net Income to Common	159.21	103.83	103.82	113.97	90.9
Net Income Growth	53.33%	0.01%	-8.91%	25.38%	31.00%
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
Shares Change (YoY)	-0.22%	0.10%	0.10%	0.15%	0.07%
EPS (Basic)	8.71	5.67	5.68	6.25	4.99
EPS (Diluted)	8.71	5.67	5.67	6.24	4.98
EPS Growth	53.68%	-0.01%	-9.13%	25.30%	31.05%
Free Cash Flow	191.57	137.04	102.8	104.24	119.97
Free Cash Flow Per Share	10.48	7.48	5.62	5.70	6.57
Dividend Per Share	-	6.000	4.500	4.500	3.750
Dividend Growth	-	33.33%	-	20.00%	25.00%
Gross Margin	81.68%	79.56%	78.45%	78.10%	76.76%
Operating Margin	28.04%	23.57%	25.22%	29.05%	26.56%
Profit Margin	22.75%	18.67%	19.92%	23.44%	21.76%
Free Cash Flow Margin	27.38%	24.64%	19.73%	21.44%	28.71%
EBITDA	212.21	146.8	146.72	157.45	127.26
EBITDA Margin	30.33%	26.39%	28.16%	32.38%	30.46%
D&A For EBITDA	16.02	15.72	15.27	16.2	16.27
EBIT	196.2	131.08	131.44	141.25	110.99
EBIT Margin	28.04%	23.57%	25.22%	29.05%	26.56%
Effective Tax Rate	23.03%	22.66%	23.21%	21.96%	20.31%
Revenue as Reported	-	562.6	526.36	491.94	427.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.